Purchase Order 75D30122P13993
- Not listed
- This is a $420,755.40 firm-fixed-price purchase order contract awarded to Mattek Corporation, a for-profit manufacturer of human tissue models and assay kits. The contract was awarded by the National Center for Advancing Translational Sciences, a civilian agency within the Department of Health and Human Services. Mattek has previously provided respiratory, skin, and intestinal human tissue models to various HHS agencies, including the National Institutes of Health, Centers for Disease Control...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (part of the National Institutes of Health) to Mattek Corporation, a small business manufacturer of human tissue models. The $98,259.02 contract is for the delivery of alveolar and tracheobronchial tissues in a ready-made format to support COVID-19 drug testing. The original solicitation was a total small business set-aside with a quick turnaround of 35 days for delivery to the NIH in...
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Mattek Corp, a foreign-owned for-profit manufacturer of human tissue models and assay kits. The $12,137 firm fixed-price purchase order is for the development of an NHBE (normal human bronchial epithelial) cell line using CRISPR/Cas or RNA interference (RNAi) technology. The contract has a small...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Mattek Corporation, a foreign-owned, for-profit manufacturer of human tissue models. The $187,370.03 award is for providing human alveolar and tracheobronchial tissues to support viral infection/disease modeling and antiviral discovery research for SARS-CoV-2. The original solicitation was a non-competitive,...
- This is a sole-source contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Mattek Corp, a for-profit manufacturer of human tissue models. The $225,126 Firm Fixed Price contract is for the delivery of human alveolar, tracheobronchial, and gut tissue samples to support NCATS' efforts to rapidly characterize SARS-CoV-2 variants and test antiviral therapies. The contract does not have a set-aside designation, as...
- This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Mattek Corporation, a for-profit manufacturer of human tissue models and assay kits. The $14,555.00 contract is for the delivery of Mattek's AMBIS #2231308 NASAL TISSUE MODEL AND EPINASAL ASSAY MEDIUM. This contract does not have a set-aside designation. Mattek has a history of providing human...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $225,000.00 firm fixed price Small Business Innovation Research (SBIR) Phase I contract to Mattek Corp, a for-profit manufacturer of human tissue models and assay kits. The contract is for the development of electrospun biodegradable membrane inserts, to be performed from July 27, 2020 to April 26, 2021. Mattek previously supported federal biomedical research...
- This firm fixed price purchase order for $949,800 was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Mattek Corporation. The contract calls for the delivery of 600 EpiAirway 3D respiratory epithelial non-human primate microtissues and 600 EpiAlveolar 3D small airway non-human primate microtissues to support SARS-CoV-2 variant and therapeutics testing being conducted by the National Institute on Drug...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Mattek Corporation, a for-profit manufacturer of human tissue models. The $20,802 contract is for the delivery of reconstructed human pigmented epidermis samples and maintenance media, to be completed by November 20, 2024. The contract has no set-aside designation. Mattek has a history of providing human tissue models to federal agencies like the National Institutes of Health (NIH), Centers for Disease...
- This is a $193,290.00 firm fixed price purchase order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Mattek Corp, a foreign-owned for-profit manufacturer of human tissue models and assay kits. The contract is for the delivery of "MEL-400-FT-C-2 NORMAL HUMAN 3D PIGMENTED" products. Mattek has previously provided respiratory, skin, and intestinal human tissue models to federal agencies like the National Institutes of Health (NIH), Centers for Disease...
The Department of Health and Human Services (HHS) awarded a $248,439 firm-fixed-price purchase order contract to Mattek Corporation, a for-profit manufacturer, for the provision of respiratory epithelial tissue models. The contract has a completion date of June 8, 2023 and was awarded on June 10, 2022 through the Centers for Disease Control and Prevention (CDC) Pittsburgh office. This contract supports the CDC's biomedical research and medical countermeasure testing needs, as Mattek has provided similar human tissue models to HHS agencies like the National Institutes of Health (NIH) and Food and Drug Administration (FDA) in the past. Mattek also supplies tissue models to other federal agencies like the Environmental Protection Agency (EPA) and Department of the Navy for chemical toxicity and wound healing research. This contract was not set aside for any socioeconomic program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($3k) | 6/25/24 | |
| Not listed | Not listed | $248.4k | 6/10/22 |